Uncovering the Potential of Phosphatidylinositol 3-Kinase Inhibitors in Cutaneous T-Cell Lymphoma: Insights from High-Throughput In Vitro Screenings

Affiliations

¹ Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
² Yale Center for Molecular Discovery, Yale University, New Haven, Connecticut, USA.
³ Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
⁴ Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut, USA. Electronic address: michael.girardi@yale.edu.

Free article

Comment

Amber Loren Ong King et al. J Invest Dermatol. 2022 Jan.

Free article

. 2022 Jan;142(1):254-257.

doi: 10.1016/j.jid.2021.04.035. Epub 2021 Jul 19.

¹ Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
² Yale Center for Molecular Discovery, Yale University, New Haven, Connecticut, USA.
³ Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
⁴ Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut, USA. Electronic address: michael.girardi@yale.edu.

No abstract available

Comment on

Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC.
Wu CH, Yang CY, Wang L, Gao HX, Rakhshandehroo T, Afghani S, Pincus L, Balassanian R, Rubenstein J, Gill R, Bandyopadhyay S, McCormick F, Moasser M, Ai WZ. Wu CH, et al. J Invest Dermatol. 2021 Feb;141(2):364-373. doi: 10.1016/j.jid.2020.05.110. Epub 2020 Jun 27. J Invest Dermatol. 2021. PMID: 32603749 Free PMC article.